Colon cancer screening

John V. Cox; Steven J. Stryker

Colon cancer screening

John V. Cox, Steven J. Stryker

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	23-26
Number of pages	4
Journal	Medical Crossfire
Volume	4
Issue number	6
State	Published - 2002

ASJC Scopus subject areas

Health Policy

Cite this

@article{9c550f57e3bf413abb852bd8446ea618,

title = "Colon cancer screening",

author = "Cox, {John V.} and Stryker, {Steven J.}",

note = "Funding Information: The second, and by far the most comprehensive screening review, was prepared by a multidisciplinary expert panel. 25 This review also included extensive modeling analysis of key screening issues. The expert panel was assembled by a contract of the Federal Agency for Health Care Policy and Research (AHCPR) with the American Gastroenterological Association (AGA). The charge was “to evaluate the evidence on colorectal screening and surveillance and to develop appropriate clinical practice guidelines based on this evidence.” Representatives from pertinent disciplines were invited to participate, and the final document was produced on behalf of and with the endorsement of a consortium of organizations, including the AGA, American Society for Gastrointestinal Endoscopy, American Society of Colon and Rectal Surgeons, American College of Gastroenterology, and Society of American Gastrointestinal Endoscopic Surgeons. Additional endorsing organizations included the American Cancer Society, American Society of Colon and Rectal Surgeons, Crohn's and Colitis Foundation of America, and Oncology Nursing Society. This was a massive effort extending over almost 2½ years. Of note, in the last year of the effort, the AHCPR terminated support of the project on the basis of restructuring of the AHCPR guideline program. The panel elected to complete the guidelines themselves under the auspices of the AGA and the sponsoring medical societies of the consortium. The recommendations therefore represent those of the expert panel and the consortium organizations but not of the AHCPR. The consortium screening recommendations for asymptomatic average-risk persons ≥50 years old included the following: (1) on the basis of strong evidence, annual FOBT or flexible sigmoidoscopy every 5 years; (2) on the basis of theoretical, but not proven findings, combined annual FOBT and flexible sigmoidoscopy every 5 years; and (3) no direct evidence of efficacy but strong rationale, double-contrast barium enema every 5–10 years or colonoscopy every 10 years. 25 Guidelines for evaluation of positive screening tests and surveillance of persons with adenomatous polyps, colon cancer, and ulcerative colitis are also given but will not be reviewed here. ",

year = "2002",

language = "English (US)",

volume = "4",

pages = "23--26",

journal = "Medical Crossfire",

issn = "1525-9404",

publisher = "Liberty Communication Network Inc",

number = "6",

}

TY - JOUR

T1 - Colon cancer screening

AU - Cox, John V.

AU - Stryker, Steven J.

N1 - Funding Information: The second, and by far the most comprehensive screening review, was prepared by a multidisciplinary expert panel. 25 This review also included extensive modeling analysis of key screening issues. The expert panel was assembled by a contract of the Federal Agency for Health Care Policy and Research (AHCPR) with the American Gastroenterological Association (AGA). The charge was “to evaluate the evidence on colorectal screening and surveillance and to develop appropriate clinical practice guidelines based on this evidence.” Representatives from pertinent disciplines were invited to participate, and the final document was produced on behalf of and with the endorsement of a consortium of organizations, including the AGA, American Society for Gastrointestinal Endoscopy, American Society of Colon and Rectal Surgeons, American College of Gastroenterology, and Society of American Gastrointestinal Endoscopic Surgeons. Additional endorsing organizations included the American Cancer Society, American Society of Colon and Rectal Surgeons, Crohn's and Colitis Foundation of America, and Oncology Nursing Society. This was a massive effort extending over almost 2½ years. Of note, in the last year of the effort, the AHCPR terminated support of the project on the basis of restructuring of the AHCPR guideline program. The panel elected to complete the guidelines themselves under the auspices of the AGA and the sponsoring medical societies of the consortium. The recommendations therefore represent those of the expert panel and the consortium organizations but not of the AHCPR. The consortium screening recommendations for asymptomatic average-risk persons ≥50 years old included the following: (1) on the basis of strong evidence, annual FOBT or flexible sigmoidoscopy every 5 years; (2) on the basis of theoretical, but not proven findings, combined annual FOBT and flexible sigmoidoscopy every 5 years; and (3) no direct evidence of efficacy but strong rationale, double-contrast barium enema every 5–10 years or colonoscopy every 10 years. 25 Guidelines for evaluation of positive screening tests and surveillance of persons with adenomatous polyps, colon cancer, and ulcerative colitis are also given but will not be reviewed here.

PY - 2002

Y1 - 2002

UR - http://www.scopus.com/inward/record.url?scp=0036307188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036307188&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:0036307188

VL - 4

SP - 23

EP - 26

JO - Medical Crossfire

JF - Medical Crossfire

SN - 1525-9404

IS - 6

ER -

Colon cancer screening

ASJC Scopus subject areas

Other files and links

Cite this